Homoeopathic treatment of widespread muscle pain in body

Efficacy of individualized homoeopathic medicines in the treatment of fibromyalgia syndrome: a double-blind, randomized, placebo-controlled clinical trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043485

Enrollment

128

Registered

2022-06-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M797- Fibromyalgia

Interventions

Intervention1: Individualized homoeopathic medicines in centesimal potencies: Each dose will consist of 4 cane sugar globules no. 10 moistened with the indicated medicine (preserved in 90% v/v ethanol

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth withi

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years. 2. Both sexes. 3. Patients suffering from FMS with WPI more than equal to 7 and SSS more than equal to 5 Or WPI 4-6 and SSS more than equal to 9. 4. Duration of the symptoms more than 3 months. 5. Literate patients; can read Bengali and/or English. 6. Providing written informed consent to participate in the trial.

Exclusion criteria

Exclusion criteria: Patient unwilling for giving consent. 2. Immuno-compromised diseases. 3. controlled psychiatric condition. 4. Pregnant or lactation women. 5. Unexplained weight changes and fever. 6. Any severe acute illness. 7. Patient suffering from any other chronic co-morbidities. 8. Patient taking any homoeopathic medicine from other sources for any chronic diseases within last 3 months. 9. Any alternative medicines taken within last 3 months. 10. Chronic alcoholism and substance abuse.

Design outcomes

Primary

Measure	Time frame
Fibromyalgia Impact questionnaire (FIQ)Timepoint: at baseline and after every 4 weeks for 12 weeks	—

Secondary

Measure	Time frame
Visual analogue scale (VAS) of pain The Psychological General Well-Being Index (PGWBI)Timepoint: at baseline and after every 4 weeks for 12 weeks	—

Countries

India

Contacts

Public ContactDR HIMANGSU HAIT

The Calcutta Homoeopathic Medical College and Hospital

haitdrhimangsu@gmail.com9433565680

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026